Your browser has javascript turned off or blocked. This will lead to some parts of our website to not work properly or at all. Turn on javascript for best performance.

The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here:

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Default user image.

Corrado Cilio


Default user image.

Beta Cell Function: from Human Genetics to Animal Models


  • Martins Kalis

Summary, in English

Beta cell function is an important factor in the development of both Type 1 (T1D) and Type 2 (T2D) diabetes mellitus. T1D is characterized by a primary defect in insulin secretion due to the immune-mediated beta cell destruction, however, the more common T2D beside insulin resistance also include impaired beta cell function as a consequence to abnormal glucose homeostasis. Genetic susceptibility is involved in both types of diabetes. We have studied several genetic and immunological factors affecting beta cell function.

First, we tested whether single nucleotide polymorphisms (SNPs) of the human Free Fatty Acid Receptor 1 (FFAR1) are associated with T2D and insulin secretion. Another genetic study focused on FOXP3 association with T1D and the disease-related clinical parameters. The role of microRNAs (miRNAs) on beta cell function was studied in the third project using a novel genetically engineered mouse model. Subsequently, the effect of Alpha 1-Antitrypsin (AAT) on cytokine-induced apoptosis and on insulin secretion was studied in beta cells in vitro.

In Study I, we concluded that SNPs rs1978013 and rs1978014 in the upstream region of FFAR1 gene might contribute to impaired beta cell function in T2D. Study II showed that the minor A allele in the FOXP3 rs2232365 SNP might represent a protective factor in T1D pathogenesis and suggest a possible role of FOXP3 in the regulation of autoimmunity against pancreatic beta cells. We have demonstrated for the first time in Study III that targeted disruption of the Dicer1 gene specifically in beta cells leads to progressive impairment of insulin secretion and diabetes development. Our findings of Study IV show that AAT stimulates insulin secretion and protects beta cells against cytokine-induced apoptosis, and these effects of AAT seems to be mediated through the cAMP pathway.


  • Diabetes - Immunovirology
  • Cellular Autoimmunity Unit-lup-obsolete

Publishing year





Lund University Faculty of Medicine Doctoral Dissertation Series



Document type



Lund University


  • Endocrinology and Diabetes


  • animal model
  • Dicer1
  • genetics
  • genetic association
  • single nucleotide polymorphism
  • SNP
  • INS-1E
  • AAT
  • FOXP3
  • beta cell function
  • insulin secretion
  • FFAR1
  • insulin
  • T2D
  • glucose
  • T1D



Research group

  • Diabetes - Immunovirology
  • Cellular Autoimmunity Unit-lup-obsolete


  • Corrado Cilio
  • Per Levéen
  • Leif Groop


  • ISSN: 1652-8220
  • ISBN: 978-91-86253-49-3

Defence date

16 May 2009

Defence time


Defence place

Clinical Research Centre Aula, MAS, Malmö


  • Décio Eizirik (Ph.D.)